Autres langues Genmab A/S Nasdaq

Actions

GMAB

US3723032062

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 24/09/2026			Varia. 5j.	Varia. 1 janv.
34,83 ^USD	+0,23 %		+1,25 %	+13,08 %

13:57	AbbVie annonce que Santé Canada a délivré un avis de conformité pour EPKINLY dans le traitement du lymphome folliculaire	MT
07:07	Hansa Biopharma recrute deux nouveaux administrateurs	FW

Autres langues

20:33	Grant of Restricted Stock Units and Warrants to Employees in Genmab
13:57	AbbVie Says Health Canada Issues Notice of Compliance for EPKINLY in Follicular Lymphoma
23/09	Morning Meeting: La tecnología vuelve a acelerar con el petróleo a la baja
09/09	Genmab A/S : has published its Articles of Association
08/09	Capital Increase in Genmab as a Result of Employee Warrant Exercise
08/09	Notice to Convene an Extraordinary General Meeting of Genmab A/S
25/08	Genmab to Participate in Upcoming Investor Conferences
20/08	Cancer vaccines finally garner the spotlight
11/08	Capital Increase in Genmab as a Result of Employee Warrant Exercise
07/08	Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data
07/08	Genmab : Q2 beat reinforces the investment story; diversification efforts remain on course
07/08	Borse europa in rialzo su settore healthcare, focus su Medio Oriente
07/08	Las bolsas europeas suben impulsadas por el sector sanitario, con el foco en Oriente Medio
07/08	U.S. Futures Mixed, European Stocks Up
07/08	Healthcare leads European shares higher; Middle East in focus
07/08	The enigmatic Mr Warsh, the labour market and interest rates
06/08	Genmab A/S Revises Earnings Guidance for the Year 2026
06/08	Genmab A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
06/08	Genmab Lifts FY26 Earnings Guidance
06/08	Genmab A/S : Interim Report for the First Half of 2026
06/08	Genmab Announces Financial Results for the First Half of 2026
24/07	Afternoon Meeting: Wall Street, bajo la presión de tres frentes
24/07	Wall Street's Three-Front Squeeze
24/07	One hundred dollars and a market beating
23/07	Stocks to Watch : Intel, Deckers, Edwards Lifesciences, Genmab